कैंसर अनुसंधान में पुरालेख

  • आईएसएसएन: 2254-6081
  • जर्नल एच-इंडेक्स: 13
  • जर्नल उद्धरण स्कोर: 3.58
  • जर्नल प्रभाव कारक: 3.12
में अनुक्रमित
  • चीन राष्ट्रीय ज्ञान अवसंरचना (सीएनकेआई)
  • उद्धरण कारक
  • ओसीएलसी- वर्ल्डकैट
  • पबलोन्स
  • चिकित्सा शिक्षा और अनुसंधान के लिए जिनेवा फाउंडेशन
  • गूगल ज्ञानी
  • गुप्त खोज इंजन लैब्स
इस पृष्ठ को साझा करें

अमूर्त

An Introduction to Immunotherapy in the Treatment of Brain Tumors

Marry Joseph*

A relatively tiny portion of all malignancies in humans are brain cancers. The intricacy and importance of the brain's function, however, result in a high morbidity and death rate for malignancies of the brain. The cerebrospinal fluid and meninges surround the neurons, supporting or glial cells, cranial nerves, glands, and blood arteries that make up the human brain, which is enclosed in a solid skull vault. Each of these cellular components has the potential to become primary brain tumours with different subtypes and levels of aggressiveness. Secondary or metastatic brain malignancies are increasingly common as a result of better control of more common cancers such breast, lung, and colon. The biology of the malignancy is the primary determinant of the clinical consequences of a brain tumour. The tumor's location and its ability to receive treatment with little side effect come next. Size, vascularity, peri-tumoral edoema, and adverse effects of treatments on the nearby normal brain are other significant factors.

Keywords

Brain; Cancer; Health care; Neuroscience

अस्वीकृति: इस सारांश का अनुवाद कृत्रिम बुद्धिमत्ता उपकरणों का उपयोग करके किया गया है और इसे अभी तक समीक्षा या सत्यापित नहीं किया गया है।